Eflornithine + Sulindac Shows No Benefit in Adenomatous Polyposis

TUESDAY, Sept. 15, 2020 -- For patients with familial adenomatous polyposis, the incidence of disease progression is not statistically significantly lower with the combination of eflornithine and sulindac versus either eflornithine or sulindac...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news